CANC Holdings Information

CANC is an equity ETF with a total of 58 individual holdings. The top holdings are Revolution Medicines stock at 7.54%, Eli Lilly and Company at 4.54%, Roche Holding AG at 4.24%, Immunome at 4.11%, and Novartis AG at 4.05%.

Total Holdings

Top 10 Percentage

42.62%

Asset Class

Equity

ETF Category

Health

Assets

176.04M

PE Ratio

19.80

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	RVMD	Revolution Medicines, Inc.	7.54%	86,450
2	LLY	Eli Lilly and Company	4.54%	7,684
3	RHHBY	Roche Holding AG	4.24%	141,653
4	IMNM	Immunome, Inc.	4.11%	315,648
5	SWX: NOVN	Novartis AG	4.05%	47,020
6	CELC	Celcuity Inc.	3.84%	47,450
7	COGT	Cogent Biosciences, Inc.	3.82%	206,419
8	LON: AZN	AstraZeneca PLC	3.58%	33,501
9	MRK	Merck & Co., Inc.	3.48%	52,978
10	BMY	Bristol-Myers Squibb Company	3.44%	101,680
11	NUVL	Nuvalent, Inc.	3.09%	53,763
12	LEGN	Legend Biotech Corporation	3.08%	194,092
13	BBIO	BridgeBio Pharma, Inc.	2.92%	73,191
14	ABBV	AbbVie Inc.	2.76%	22,700
15	EXEL	Exelixis, Inc.	2.73%	96,885
16	JNJ	Johnson & Johnson	2.62%	19,900
17	CGON	CG Oncology, Inc.	2.52%	68,702
18	GMAB	Genmab A/S	2.44%	158,861
19	IDYA	IDEAYA Biosciences, Inc.	2.28%	135,847
20	ZLAB	Zai Lab Limited	2.13%	196,972
21	AMGN	Amgen Inc.	2.11%	11,019
22	ONC	BeOne Medicines AG	2.02%	11,505
23	ZYME	Zymeworks Inc.	1.50%	105,615
24	ELVN	Enliven Therapeutics, Inc.	1.39%	58,197
25	HALO	Halozyme Therapeutics, Inc.	1.27%	32,598

Showing 25 of 58 holdings

Subscribe to see the full list

Activate Now

As of May 21, 2026